ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, ...

An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and ...

For startups, patents are often the first line of defense in building a competitive moat. They signal to investors that your ...

Aspire Biopharma (ASBP) announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery technology. This application – which seeks patent ...

A petition for certiorari is currently pending before the United States Supreme Court which raises serious concerns as to fundamental principles of patent law, especially relating to the enablement ...

American tech firm Natsoft and its subsidiary Updraft have sued Mumbai-based Hexaware Technologies for $500 million in the US ...

Patent filings from Rivian detail an ornamental headlamp design, as well as a home energy storage system similar to Tesla's ...

Consider that a pharmaceutical company (for these purposes, the “innovator”) holds the patent for a vital drug for a ...

Corning Inc. has published a patent describing edible microcarriers and support structures for cultivated meat production, ...

The filing was in Cambodia, but the fact that GM is bothering to keep the name current is, at the very least, a positive sign ...

Suunto is claiming damages and a court injunction that would forbid Garmin from selling devices that use the patented ...